title: [Prevention and multimodal therapy of hyperthyroidism].
abstract: Subclinical and overt hyperthyroidism have been associated with various negative clinical outcomes as for example an increased risk of atrial fibrillation or increased cardiovascular mortality, especially in old age. In order to avoid hyperthyroidism it is strongly recommended not to start any iodine containing drug therapy or to avoid application of contrast agents unless the patient presents with an unremarkable clinical course. TSH suppressive therapy for the treatment of endemic goiter or differentiated low risk thyroid carcinoma is unnecessary, since it favours the development of subclinical hyperthyroidism. Overt hyperthyroidism is treated with antithyroid drugs and/or radioiodine therapy or surgery according to the underlying disease (toxic nodular goiter, Graves' disease).
authors.affiliation: Klinik für Endokrinologie, Diabetologie, Angiologie und Innere Medizin, Klinikum Neuperlach, Städtisches Klinikum München GmbH, München, Deutschland. kd.palitzsch@kh-neuperlach.de
authors.forename: K-D
authors.initials: KD
authors.lastname: Palitzsch
mesh_terms: D013956:Antithyroid Agents / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D006980:Hyperthyroidism / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008111:Liver Function Tests; D013963:Thyroid Hormones / Q000097:blood; D013965:Thyroidectomy
chemical_list: D013956:Antithyroid Agents; D007457:Iodine Radioisotopes; D013963:Thyroid Hormones